Profiel
Priyanka Shah is currently working as the VP of Investor Relations & Communications at Kinnate Biopharma, Inc. Previously, she worked as the Head of Media Relations at Mirati Therapeutics, Inc.
Actieve functies van Priyanka Shah
| Bedrijven | Functie | Begin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Investor Relations Contact | - |
Eerdere bekende functies van Priyanka Shah
| Bedrijven | Functie | Einde |
|---|---|---|
| MIRATI THERAPEUTICS | Public Communications Contact | 01-04-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
